teva pharmaceuticals introduces the first generic glp-1 for weight loss FDA Approves Version of Liraglutide Injection, a Teva Launches First Generic Weight

Members frequently note a decrease in alcohol desire and enjoyment while on GLP-1 medications

The most common side effects include nausea, gastrointestinal discomfort, changes in appetite, and feeling full more quickly

GLP-1s work best when paired with a balanced, highprotein, highfiber diet and regular movement

OTC GLP-1 alternatives lack comparable clinical data, with most studies on individual ingredients showing modest effects in isolation, not in combination formulations

doi: 10.3389/fendo.2025.1570603 Received 03 February 2025 Accepted 29 April 2025 Published 21 May 2025 Volume 16 - 2025 Edited by Jared Rutter, The University of Utah, United States Reviewed by Steven Patterson, Glasgow Caledonian University, United Kingdom Elena Jimenez Marti, University of Valencia, Spain Nigel Irwin, Ulster University, United Kingdom Updates Copyright 2025 Koefoed-Hansen, Helsted, Kizilkaya, Lund, Rosenkilde and Gasbjerg

What have you learned about them through your research